Optimizing the downstream process for adeno-associated virus (AAV) production with consistent quality depends on the ability to characterize critical quality attributes affecting the final product’s ...
This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...
Manufacturing differences between ranibizumab and aflibercept biosimilars might shape pricing, uptake, and patient access globally.
The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...
Drug Substance manufacturing is a critical component of pharmaceutical production, requiring precise processes, rigorous quality control, and innovative solutions to overcome various challenges. From ...
SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...
SANTA CLARA, Calif., Feb. 20, 2018 /CNW/ -- Based on its recent analysis of the biologics downstream processing technologies industry, Frost & Sullivan recognizes 3M with the 2017 Global Product ...
Regulating manufacturing processes in the medical device industry is challenging. But process signature verification can help manufacturers get a handle on problems before they get out of control.
The global PAEK-based solutions provider announced – as part of its 2015 financial results – that it will build a new PEEK composite facility for unidirectional (UD) tape and add new manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback